You are here: Home » Current Affairs » Coronavirus » News
Business Standard

USFDA authorises two changes to Moderna's vaccine against coronavirus

The US Food and Drug Administration has authorised two changes to Moderna's Covid-19 vaccine that can provide extra doses from each vial

Topics
USFDA | Coronavirus Vaccine

AP  |  Washington 

moderna, covid, vaccine, pharma, coronavirus, medicine, drugs, medical research, covid, lab
Moderna's Covid-19 vaccine shots

The US Food and Drug Administration has authorised two changes to Moderna's COVID-19 vaccine that can provide extra doses from each vial.

The agency said late Thursday it approved new vials from Moderna that can contain up to 15 doses each, compared with the original vials designed to hold 10 doses. Additionally, regulators said providers can safely extract up to 11 doses from the original 10-dose vials. Those changes will be added to instructions for health care workers.

The dosing updates should help bolster US supplies and speed vaccinations as the US nears 100 million inoculations against COVID-19. President Joe Biden has vowed to provide enough shots to vaccinate all US adults by late May and recently set a new goal of administering 200 million injections within his first 100 days in office.

Moderna said in a statement it plans to begin shipping the new 15-dose vials in coming weeks. The company submitted updated data to FDA showing how much vaccine can be extracted from each vial using different types of syringes.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Fri, April 02 2021. 12:40 IST
RECOMMENDED FOR YOU